Journal articles on the topic 'PCSK1'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'PCSK1.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Parvaz, Najmeh, and Zahra Jalali. "Molecular evolution of PCSK family: Analysis of natural selection rate and gene loss." PLOS ONE 16, no. 10 (October 28, 2021): e0259085. http://dx.doi.org/10.1371/journal.pone.0259085.
Gagnon, Jeffrey, Janice Mayne, Majambu Mbikay, John Woulfe, and Michel Chrétien. "Expression of PCSK1 (PC1/3), PCSK2 (PC2) and PCSK3 (furin) in mouse small intestine." Regulatory Peptides 152, no. 1-3 (January 2009): 54–60. http://dx.doi.org/10.1016/j.regpep.2008.07.006.
Xu, Xu, Egor Volcotrub, and Svetlana B. Ten. "LBSUN131 Leptin Level, BMI And Genetics In Early Onset Obesity." Journal of the Endocrine Society 6, Supplement_1 (November 1, 2022): A5. http://dx.doi.org/10.1210/jendso/bvac150.009.
Clément, Karine, Martin Wabitsch, Erica Van den Akker, Jesús Argente, Ceclila Scimia, Madhura Srinivasan, Guojun Yuan, and Peter Kühnen. "ODP607 Long-term Efficacy of Setmelanotide in Patients With POMC or LEPR Deficiency Obesity." Journal of the Endocrine Society 6, Supplement_1 (November 1, 2022): A14—A15. http://dx.doi.org/10.1210/jendso/bvac150.030.
Aerts, Laetitia, Nathalie A. Terry, Nina N. Sainath, Clarivet Torres, Martín G. Martín, Bruno Ramos-Molina, and John W. Creemers. "Novel Homozygous Inactivating Mutation in the PCSK1 Gene in an Infant with Congenital Malabsorptive Diarrhea." Genes 12, no. 5 (May 10, 2021): 710. http://dx.doi.org/10.3390/genes12050710.
Velazquez-Roman, Jorge, Uriel A. Angulo-Zamudio, Nidia Leon-Sicairos, Hector Flores-Villaseñor, Miriam Benitez-Baez, Ana Espinoza-Salomón, Alejandra Karam-León, et al. "Association of PCSK1 and PPARG1 Allelic Variants with Obesity and Metabolic Syndrome in Mexican Adults." Genes 14, no. 9 (September 8, 2023): 1775. http://dx.doi.org/10.3390/genes14091775.
Ayers, Kristin L., Benjamin S. Glicksberg, Alastair S. Garfield, Simonne Longerich, Joseph A. White, Pengwei Yang, Lei Du, et al. "Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment." Journal of Clinical Endocrinology & Metabolism 103, no. 7 (May 2, 2018): 2601–12. http://dx.doi.org/10.1210/jc.2018-00258.
Van Dijck, Evelien, Sigri Beckers, Sara Diels, Tammy Huybrechts, An Verrijken, Kim Van Hoorenbeeck, Stijn Verhulst, Guy Massa, Luc Van Gaal, and Wim Van Hul. "Rare Heterozygous PCSK1 Variants in Human Obesity: The Contribution of the p.Y181H Variant and a Literature Review." Genes 13, no. 10 (September 27, 2022): 1746. http://dx.doi.org/10.3390/genes13101746.
Morash, Michael G., Angela B. MacDonald, Roger P. Croll, and Younes Anini. "Molecular cloning, ontogeny and tissue distribution of zebrafish (Danio rerio) prohormone convertases: pcsk1 and pcsk2." General and Comparative Endocrinology 162, no. 2 (June 2009): 179–87. http://dx.doi.org/10.1016/j.ygcen.2009.03.013.
Sanders, SS. "PCSK1 variants: genetic risk factors for obesity." Clinical Genetics 75, no. 4 (April 2009): 318–19. http://dx.doi.org/10.1111/j.1399-0004.2009.01171_1.x.
Farooqi, Sadaf, Jennifer Lynne Miller, Olga Ohayon, Guojun Yuan, Murray Stewart, Cecilia Scimia, and Jack Yanovski. "Effects of Setmelanotide in Patients With POMC, PCSK1, or LEPR Heterozygous Deficiency Obesity in a Phase 2 Study." Journal of the Endocrine Society 5, Supplement_1 (May 1, 2021): A669—A670. http://dx.doi.org/10.1210/jendso/bvab048.1367.
Clément, Karine, Erica L. T. van den Akker, Gregory Gordon, Guojun Yuan, and Peter Kühnen. "Timing of Onset of Adverse Events With Setmelanotide, an MC4R Agonist, in Patients With Severe Obesity Due to LEPR or POMC Deficiency." Journal of the Endocrine Society 5, Supplement_1 (May 1, 2021): A30—A31. http://dx.doi.org/10.1210/jendso/bvab048.058.
Wabitsch, Martin, Sadaf Farooqi, Jesús Argente, Erica van den Akker, Guojun Yuan, Olga Ohayon, and Cecilia Scimia. "RF24 | PSUN96 Setmelanotide in Patients With Heterozygous POMC, LEPR, SRC1, or SH2B1 Obesity: Design of EMANATE – A Placebo-Controlled Phase 3 Trial." Journal of the Endocrine Society 6, Supplement_1 (November 1, 2022): A37. http://dx.doi.org/10.1210/jendso/bvac150.076.
Farooqi, Sadaf, Jennifer Miller, Olga Ohayan, Cecilia Scimia, Christopher Still, Marianne Yohn, Guojun Yuan, Jesús Argente, and Brieana Buckley. "OR10-1 Body Mass Index and Weight Reductions in Patients With Obesity Due to Heterozygous Variants in POMC, PCSK1, and LEPR After 1 Year of Setmelanotide." Journal of the Endocrine Society 6, Supplement_1 (November 1, 2022): A15. http://dx.doi.org/10.1210/jendso/bvac150.031.
Pickett, Lindsay A., Michael Yourshaw, Valeria Albornoz, Zijun Chen, R. Sergio Solorzano-Vargas, Stanley F. Nelson, Martín G. Martín, and Iris Lindberg. "Functional Consequences of a Novel Variant of PCSK1." PLoS ONE 8, no. 1 (January 28, 2013): e55065. http://dx.doi.org/10.1371/journal.pone.0055065.
Herrmann, G., M. Wabitsch, and J. von Schnurbein. "Monogene Formen der Adipositas beim Menschen." Adipositas - Ursachen, Folgeerkrankungen, Therapie 12, no. 04 (December 2018): 162–67. http://dx.doi.org/10.1055/s-0038-1676672.
Benzinou, Michael, John W. M. Creemers, Helene Choquet, Stephane Lobbens, Christian Dina, Emmanuelle Durand, Audrey Guerardel, et al. "Common nonsynonymous variants in PCSK1 confer risk of obesity." Nature Genetics 40, no. 8 (July 6, 2008): 943–45. http://dx.doi.org/10.1038/ng.177.
Chrétien, Michel, and Majambu Mbikay. "60 YEARS OF POMC: From the prohormone theory to pro-opiomelanocortin and to proprotein convertases (PCSK1 to PCSK9)." Journal of Molecular Endocrinology 56, no. 4 (May 2016): T49—T62. http://dx.doi.org/10.1530/jme-15-0261.
Zheng, Xiaoya, Wei Ren, Suhua Zhang, Jingjing Liu, Sufang Li, Jinchao Li, Ping Yang, Jun He, Shaochu Su, and Ping Li. "Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population." Molecular Biology Reports 39, no. 1 (March 25, 2011): 17–23. http://dx.doi.org/10.1007/s11033-011-0705-6.
Stijnen, Pieter, Bruno Ramos-Molina, Stephen O'Rahilly, and John W. M. Creemers. "PCSK1 Mutations and Human Endocrinopathies: From Obesity to Gastrointestinal Disorders." Endocrine Reviews 37, no. 4 (May 17, 2016): 347–71. http://dx.doi.org/10.1210/er.2015-1117.
Ramos-Molina, Bruno, María Molina-Vega, José Fernández-García, and John Creemers. "Hyperphagia and Obesity in Prader–Willi Syndrome: PCSK1 Deficiency and Beyond?" Genes 9, no. 6 (June 7, 2018): 288. http://dx.doi.org/10.3390/genes9060288.
Gu, Q., M. Yazdanpanah, M. van Hoek, A. Hofman, X. Gao, F. W. M. de Rooij, and E. J. G. Sijbrands. "Common variants in PCSK1 influence blood pressure and body mass index." Journal of Human Hypertension 29, no. 2 (July 17, 2014): 82–86. http://dx.doi.org/10.1038/jhh.2014.59.
Frank, Graeme R., Joyce Fox, Ninfa Candela, Zorica Jovanovic, Elena Bochukova, Jeremiah Levine, Peter R. Papenhausen, Stephen O'Rahilly, and I. Sadaf Farooqi. "Severe obesity and diabetes insipidus in a patient with PCSK1 deficiency." Molecular Genetics and Metabolism 110, no. 1-2 (September 2013): 191–94. http://dx.doi.org/10.1016/j.ymgme.2013.04.005.
Chang, Yi-Cheng, Yen-Feng Chiu, Kuang-Chung Shih, Ming-Wei Lin, Wayne Huey-Herng Sheu, Timothy Donlon, Jess David Curb, et al. "Common PCSK1 Haplotypes Are Associated With Obesity in the Chinese Population." Obesity 18, no. 7 (July 2010): 1404–9. http://dx.doi.org/10.1038/oby.2009.390.
Maly Majeed, Anas Hussain. "In-Silico Analysis of Nonsynonymous Single Nucleotide Polymorphism in Human PCSK1 Gene." Bioscience Biotechnology Research Communications 14, no. 1 (March 25, 2021): 215–19. http://dx.doi.org/10.21786/bbrc/14.1/31.
TAYLOR, AUSTIN, YI-CHUN CHEN, and BRUCE VERCHERE. "2105-P: Beta Cell PCSK1 Deficiency Increases Diabetes Susceptibility in Male Mice." Diabetes 69, Supplement 1 (June 2020): 2105—P. http://dx.doi.org/10.2337/db20-2105-p.
Shan, Limin, Jiajie Sun, Chunlei Zhang, Xingtang Fang, Chuzhao Lei, Xianyong Lan, and Hong Chen. "The polymorphisms of bovine PCSK1 gene and their associations with growth traits." Genes & Genomics 33, no. 1 (February 2011): 57–63. http://dx.doi.org/10.1007/s13258-010-0049-y.
Muhsin, Nor I. A., Liz Bentley, Ying Bai, Michelle Goldsworthy, and Roger D. Cox. "A novel mutation in the mouse Pcsk1 gene showing obesity and diabetes." Mammalian Genome 31, no. 1-2 (January 23, 2020): 17–29. http://dx.doi.org/10.1007/s00335-020-09826-4.
Kaur, Harleen, Beverly S. Muhlhausler, Pamela Su-Lin Sim, Amanda J. Page, Hui Li, Maria Nunez-Salces, Georgia S. Clarke, et al. "Pregnancy, but not dietary octanoic acid supplementation, stimulates the ghrelin-pituitary growth hormone axis in mice." Journal of Endocrinology 245, no. 2 (May 2020): 327–42. http://dx.doi.org/10.1530/joe-20-0072.
Blanco, Elias H., Bruno Ramos-Molina, and Iris Lindberg. "Revisiting PC1/3 Mutants: Dominant-Negative Effect of Endoplasmic Reticulum-Retained Mutants." Endocrinology 156, no. 10 (July 24, 2015): 3625–37. http://dx.doi.org/10.1210/en.2015-1068.
Du, Qingyang, Rui Shao, Wentao Wang, Hui Zhang, Xinmeng Liao, Zhihao Wang, Zhan Yin, et al. "Vitamin D3 Regulates Energy Homeostasis under Short-Term Fasting Condition in Zebrafish (Danio Rerio)." Nutrients 16, no. 9 (April 25, 2024): 1271. http://dx.doi.org/10.3390/nu16091271.
Duclaux-Loras, Rémi, Patrice Bourgeois, Pierre-Marie Lavrut, Fabienne Charbit-Henrion, Pauline Bonniaud-Blot, Raphael Maudinas, Marie Bournez, et al. "A novel mutation of PCSK1 responsible for PC1/3 deficiency in two siblings." Clinics and Research in Hepatology and Gastroenterology 45, no. 6 (November 2021): 101640. http://dx.doi.org/10.1016/j.clinre.2021.101640.
Pyun, Jung-A., Sunshin Kim, Dong Hyun Cha, and KyuBum Kwack. "Epistasis between polymorphisms in PCSK1 and DBH is associated with premature ovarian failure." Menopause 21, no. 11 (November 2014): 1249–53. http://dx.doi.org/10.1097/gme.0000000000000226.
Zhang, Hui, Xiaoxiang Hu, Zhipeng Wang, Yuandan Zhang, Shouzhi Wang, Ning Wang, Li Ma, et al. "Selection Signature Analysis Implicates the PC1/PCSK1 Region for Chicken Abdominal Fat Content." PLoS ONE 7, no. 7 (July 11, 2012): e40736. http://dx.doi.org/10.1371/journal.pone.0040736.
Kummerfeld, Delf-Magnus, Boris V. Skryabin, Juergen Brosius, Sergey Y. Vakhrushev, and Timofey S. Rozhdestvensky. "Reference Genes across Nine Brain Areas of Wild Type and Prader-Willi Syndrome Mice: Assessing Differences in Igfbp7, Pcsk1, Nhlh2 and Nlgn3 Expression." International Journal of Molecular Sciences 23, no. 15 (August 5, 2022): 8729. http://dx.doi.org/10.3390/ijms23158729.
García-Martínez, A., D. A. Cano, A. Flores-Martínez, J. Gil, M. Puig-Domingo, S. M. Webb, A. Soto-Moreno, and A. Picó. "Why don’t corticotroph tumors always produce Cushing’s disease?" European Journal of Endocrinology 181, no. 3 (September 2019): 351–61. http://dx.doi.org/10.1530/eje-19-0338.
Panigrahi, Sunil K., Kana Meece, and Sharon L. Wardlaw. "Effects of Naltrexone on Energy Balance and Hypothalamic Melanocortin Peptides in Male Mice Fed a High-Fat Diet." Journal of the Endocrine Society 3, no. 3 (January 28, 2019): 590–601. http://dx.doi.org/10.1210/js.2018-00379.
Chou, Chia-Lin, Tzu-Ju Chen, Cheng-Yi Lin, Sung-Wei Lee, Shih-Chang Wang, Shou-Sheng Chu, and Ching-Chieh Yang. "PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis." OncoTargets and Therapy Volume 13 (April 2020): 3141–50. http://dx.doi.org/10.2147/ott.s243750.
Kilpelainen, T. O., S. A. Bingham, K. T. Khaw, N. J. Wareham, and R. J. F. Loos. "Association of variants in the PCSK1 gene with obesity in the EPIC-Norfolk study." Human Molecular Genetics 18, no. 18 (June 15, 2009): 3496–501. http://dx.doi.org/10.1093/hmg/ddp280.
Qi, Qibin, Huaixing Li, Ruth J. F. Loos, Chen Liu, Frank B. Hu, Hongyu Wu, Zhijie Yu, and Xu Lin. "Association of PCSK1 rs6234 with Obesity and Related Traits in a Chinese Han Population." PLoS ONE 5, no. 5 (May 17, 2010): e10590. http://dx.doi.org/10.1371/journal.pone.0010590.
Philippe, J., P. Stijnen, D. Meyre, F. De Graeve, D. Thuillier, J. Delplanque, G. Gyapay, et al. "A nonsense loss-of-function mutation in PCSK1 contributes to dominantly inherited human obesity." International Journal of Obesity 39, no. 2 (June 3, 2014): 295–302. http://dx.doi.org/10.1038/ijo.2014.96.
CHEN, JIE, MEI YANG, KEHUI ZHAO, AIMIN XU, and QINGYANG HUANG. "Polymorphisms in FTO, TMEM18 and PCSK1 are associated with BMI in southern Chinese population." Journal of Genetics 93, no. 2 (August 2014): 509–12. http://dx.doi.org/10.1007/s12041-014-0384-x.
Seidah, Nabil G., Antonella Pasquato, and Ursula Andréo. "How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?" Viruses 13, no. 7 (June 25, 2021): 1229. http://dx.doi.org/10.3390/v13071229.
Ahmed, Amna Basheer M., and Badr M. Rasheed Alsaleem. "Enteroendocrine Dysfunction in Two Saudi Sisters." Case Reports in Gastroenterology 15, no. 1 (March 4, 2021): 290–95. http://dx.doi.org/10.1159/000511761.
Choi, Seungbum, Aleksandra Aljakna, and Ron Korstanje. "GW28-e0704 PCSK1 MUTANT MICE DISPLAY INCREASED APOA1 LEVEL AND DECREASED PLTP ACTIVITIY IN SERUM." Journal of the American College of Cardiology 70, no. 16 (October 2017): C64—C65. http://dx.doi.org/10.1016/j.jacc.2017.07.220.
Stijnen, Pieter, Krizia Tuand, Tibor V. Varga, Paul W. Franks, Bert Aertgeerts, and John W. M. Creemers. "The Association of Common Variants in PCSK1 With Obesity: A HuGE Review and Meta-Analysis." American Journal of Epidemiology 180, no. 11 (October 29, 2014): 1051–65. http://dx.doi.org/10.1093/aje/kwu237.
Villalobos-Comparán, Marisela, Hugo Villamil-Ramírez, Teresa Villarreal-Molina, Elena Larrieta-Carrasco, Paola León-Mimila, Sandra Romero-Hidalgo, Leonor Jacobo-Albavera, et al. "PCSK1 rs6232 Is Associated with Childhood and Adult Class III Obesity in the Mexican Population." PLoS ONE 7, no. 6 (June 21, 2012): e39037. http://dx.doi.org/10.1371/journal.pone.0039037.
Argente, J., S. Farooqi, E. Van Den Akker, S. Malhotra, P. Kühnen, K. Clément, and M. Wabitsch. "Caractéristiques cliniques des porteurs de variants sur les gènes POMC, PCSK1, LEPR, NCOA1 et SH2B1." Annales d'Endocrinologie 84, no. 5 (October 2023): 669. http://dx.doi.org/10.1016/j.ando.2023.07.467.
Chetty, K., A. Khathi, S. Schneider, and Gerda Martha Marx. "Type 2 Diabetes Mellitus Serum Biomarker Levels and Associated Single Nucleotide Polymorphisms in a South African Population." Series of Endocrinology, Diabetes and Metabolism 5, no. 3 (October 12, 2023): 100–118. http://dx.doi.org/10.54178/jsedmv5i3001.
TAYLOR, AUSTIN, YI-CHUN CHEN, DANIEL PASULA, DAN S. LUCIANI, and BRUCE VERCHERE. "123-OR: Deletion of Both Pcsk1 And Pcsk2 in Beta Cells: Lack of Mature Insulin Drives Beta-Cell Expansion and Dysfunction, but Not Severe Diabetes in Mice." Diabetes 70, Supplement 1 (June 2021): 123—OR. http://dx.doi.org/10.2337/db21-123-or.